If you could vote on Brexit now which option would you choose?
   

Regeneron's antibody cocktail can protect against COVID-19 for up to 8 months, giving hope to the immunocompromised


People with compromised immune systems who are unable to develop adequate responses to vaccines may soon have an option to protect against COVID-19. A phase 3 trial of Regeneron’s antibody cocktail showed the treatment reduced the risk of infection by 81.6% over a period of two to eight months. Results previously reported in the New England Journal of Medicine from the same trial showed that REGEN-COV reduced the risk of infection by 81.4% during the first month after administration. “These results demonstrate that REGEN-COV has the potential to provide long-lasting immunity from SARS-CoV-2 infection, a result particularly important to those who do not respond to COVID-19 vaccines, including people who are immunocompromised,” Myron Cohen, M.D., a University of North Carolina professor who leads the monoclonal antibody efforts for the NIH-sponsored COVID prevention network, said in a statement.

FiercePharma - November 8, 2021

View the full story here: https://www.fiercepharma.com/pharma/data-show-regeneron-antibody-cocktail-sustains-protection-vs-covid-19-giving